Home » Topics » Drugs » Immuno-oncology

Immuno-oncology
RSS

Daiichi Sankyo and AstraZeneca enter copromotion agreement for denosumab in Japan

May 24, 2011

Northwest Biotherapeutics and Fraunhofer enter partnership for DCVax-L

May 20, 2011

CITN selects recombinant IL-7 CYT-107 for clinical testing at network institutions

May 18, 2011

AMP-224 boosts BCG-induced immune responses against bladder cancer

May 18, 2011

Promising phase II data reported on CT-011 in diffuse large B-cell lymphoma

May 17, 2011

EpiCept files protocol for confirmatory phase III Ceplene trial in AML

May 10, 2011

T cells transduced with GD2-specific receptor 14.G2aCD28zeta lyse Ewing sarcoma cells in vitro

May 9, 2011

Oxford BioMedica and Pfizer expand licensing agreement for 5T4 antibody

May 6, 2011

ImmunoCellular Therapeutics updates long-term data from phase I ICT-107 trial in glioblastoma

May 6, 2011

Antibody 12D7 shows therapeutic efficacy against cancer in combination with chemotherapy

May 6, 2011

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
New mechanism of action identified for QC-6352
BioWorld Science
QC-6352 is a small molecule developed to inhibit the histone demethylase 4 (KDM4) that has shown potent antitumoral activity and which has a derivative named...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...